#FightUTI: Breakthrough single-dose antibiotic seen to increase patient compliance

A common condition like a trivial painful urination can lead to severe infection of the urinary bladder and the kidney, if left unattended.

In a recent symposium organized The Cathay Drug Co Inc and Zambon Italy, four international and two local doctors presented the latest available guidelines in Urinary Tract Infection (UTI) management to local specialists.

So much more women suffer from UTI than men. In fact, one in five women will experience UTI in her lifetime, and up to 80% of such cases will be repeated.

UTI may lead to high blood pressure in pregnant women, or lead to premature childbirth. Diabetes patients and those with weak immunity, people with stones in the urinary tract, children born with abnormal or narrow urinary tracts and patients using catheters are at greater risk of contracting UTI.

During the symposium, Dr. George Zhanel of the University of Manitoba (Canada) Faculty of Medicine discussed antibiotic resistance in relation to UTI. Dr. Andrea Novelli of the University Hospital Careggi (Italy) gave an overview of antibiotics therapy. Professor Nicola Petrosillo of Lazzaro Spallanzani (National Institute for Infectious Diseases, Italy) spoke about the stewardship of community and hospital-acquired infections.

Dr. Kurt Naber of the Technical University of Munich (Germany) presented international UTI treatment guidelines. Dr. Ricardo Manalastas, Jr. of the University of the Philippines (UP) College of Medicine tackled UTI in relation to pregnancy and menopause. Dr. Edsel Salvana of the National Institutes of Health, UP Manila presented local UTI treatment guidelines.

Introduced at the event was Monurol (Fosfomycin Trometamol), a unique and highly effective treatment positioned as a first line antibiotic treatment for UTI and acute cystitis (inflammation/infection of the urinary bladder). The novelty of Monurol is its single dose regimen that assures excellent patient compliance. A One time . One Dose regimen unique to the drug. as it maintain a very high urinary concentration for more than 72 hours after a single dose. This compares with common antibiotics that must be taken twice a day for seven to 14 days, depending on the severity of the infection.

Monurol also has extremely low global antibiotic resistance rates, assuring its effectiveness and the prompt relief of symptoms.

Patients suffering from UTI, acute cystitis and infection of the kidney may benefit from Monurol and should ask their doctors about it.